Peripheral Nervous System Diseases

26 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Peripheral Nervous System Diseases
Treatment and conditionWhere it standsTrials
Active tDCS with Sternberg task for neuralgiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Capivasertib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carboplatin + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carboplatin + ELRAGLUSIB + Paclitaxel for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexmedetomidine hydrochloride for dysautonomia, familialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Doxorubicin hydrochloride + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elraglusib for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + NAB-PACLITAXEL + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex-cipn for peripheral nervous system diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + Metformin + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
FULVESTRANT + Tersolisib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Imifoplatin for peripheral nervous system diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Leia Sensory Prosthesis for peripheral nervous system diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lomustine + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Methylcobalamin for peripheral nervous system diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Neridronic acid for reflex sympathetic dystrophyPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide riboside for peripheral nervous system diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NTLA-2001 for polyneuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for neuralgiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
ROC-101 for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TAMOXIFEN + FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + IMLUNESTRANT + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tersolisib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VCA-894A for charcot-marie-tooth diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VER-01 for neuralgiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1